ENGLISH VERSION UNDER CONSTRUCTION
Go to the official Italian Site for more infos
The research hospital "Casa Sollievo della Sofferenza", is owned by the Holy See and controlled through its statutory organs by the "Fondazione Casa Sollievo della Sofferenza", a foundation recognized by the Italian law as a non profit entity. The Board of Directors is designated by the Cardinal Secretary of State of the Holy See.
The hospital hosts nearly all medical specialties and has an average of 57.000 inpatients every year (10.000 of them are treated in a Day Surgery/Day Hospital regimen), 17% of the patients come from outside the Puglia region. The Casa is organized in 9 departments (40 clinical units) as follows:
• Emergency Medicine
• Developing Age
• Clinical Pathology
• Surgical Sciences
• Medical Sciences
• Radiological Sciences
The hospital provides cutting-edge diagnostic and treatment options thanks to its highly qualified professionals and medical equipments. The hospital owns: 1 "Da Vinci" Surgical Robot, 1 CT/PET, 3 linear accelerators, 4 CT (one of which is a 64 multislice device), 1 Ct simulator for Radiotherapy, 4 NMR (one of which with a 3 Tesla magnetic field, one of the first high field devices installed in Europe), 3 digital angiographers, 2 Gamma cameras and a Picture Archiving and Communication System that serves the filmless Radiology department.
The Institute counts up an average of 2500 employees, more than 100 of which are doctors, biologists, and technicians involved in scientific research on a regular basis. About 170 scientific articles are published yearly on the most acknowledged scientific journals (e.g. Science, the New England Journal of Medicine, Nature Genetics).
The SCIMAGO World Report 2012 included Casa Sollievo Institute in its world list, ranking it 9th in Italy for its scientific output, the first in Southern Italy both for total output and high quality publications (i.e. publications on peer-reviewed journals ranked in the first quartile of their category).
The Casa Sollievo Hospital was given the status of Research Institute (IRCCS) by the Ministry of Health in 1991, making it the only Italian IRCCS specifically dedicated to inherited genetic diseases, with its seven main units/laboratories of: Medical Genetics, Diabetology and Endocrinology, Gastroenterology, Hemostasis and Thrombosis, Geriatrics and Gerontology, Oncology, and the CSS-Mendel Institute of genetics branch in Rome. These research units are mostly funded on a project basis by the Italian Ministry of Health and entities such as the European Commission, plus several public and private funding agencies.
Nowadays research activities focus on the field of genetic diseases, innovative therapies and regenerative medicine.